Seborrheic Keratosis Treatment 2018: Global Market Analysis by Treatment Type and Geography - Forecast to 2026

Dublin, July 02, 2018 (GLOBE NEWSWIRE) -- The "Global Seborrheic Keratosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

The global seborrheic keratosis treatment market is expected to reach US$ 1,320.8 million by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market.

Although surgical treatments are available in the market to treat seborrheic keratosis, a topical solution (40% hydrogen peroxide - Eskata by Aclaris Therapeutics) is approved by the FDA in 2017, which may augment the market growth due to expected improvement in treatment adherence.

Furthermore, Aclaris Therapeutics has also filed an application in the European regulatory agencies for approval. The approval of the topical solution along with the ongoing research for other therapeutics will contribute to the growth of the seborrheic keratosis treatment market during the forecast period.

The global seborrheic keratosis treatment market is segmented into surgical treatments and topical solution treatments. Surgical treatments segment is further categorized into cryosurgery, electrocautery, curettage, and laser ablation. Topical solution treatment segment includes the currently approved 40% hydrogen peroxide solution.

While destructive treatments such as cryotherapy and curettage will remain the gold standard for seborrheic keratosis treatment, new therapies such as laser beam treatment and topical applications are anticipated to achieve more efficiency with comfort and convenience for patients.

Based on geographical segmentation, North America dominated the global market with more than 30% market share in 2017, and projected to hold its dominance during the forecast period. High prevalence of seborrheic keratosis and adoption of advanced treatment technologies in the region drives the North America market.

Asia Pacific and Latin America markets are anticipated to experience the fastest growth during the forecast period owing to phenomenal growth in demand for skin care and aesthetic products in the regions.

Key Topics Covered

Chapter 1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I - Secondary Research
1.4.2. Phase II - Primary Research
1.4.3. Phase III - Expert Panel Review
1.4.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Seborrheic Keratosis Treatment Market Portraiture
2.2. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Seborrheic Keratosis Treatment Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Seborrheic Keratosis Treatment Market: Market Dynamics and Future Outlook
3.1. Overview
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Growing Prevalence of Seborrheic Keratosis
3.2.1.2. Driver 2
3.2.2. Challenges
3.2.2.1. Challenge 1
3.2.2.2. Challenge 2
3.2.3. Opportunities
3.2.3.1. Opportunity 1
3.3. Attractive Investment Proposition, by Geography, 2017
3.4. Competitive Landscape, by Key Players, 2017

Chapter 4. Global Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Surgical Treatment
4.2.1. Cryosurgery
4.2.2. Electrocautery
4.2.3. Curettage
4.2.4. Laser Ablation
4.3. Topical Solution Treatment
4.3.1. Hydrogen Peroxide 40% Solution (Eskata)
4.4. Pipeline Drugs (Qualitative Information)
4.4.1. EPI SK14 (EpiPharm AG)

Chapter 5. Global Seborrheic Keratosis Treatment Market, by Geography, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. North America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.2.1. North America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.2.2. North America Seborrheic Keratosis Treatment Market, by Country, 2016 - 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.3.1. Europe Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.3.2. Europe Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.4.1. Asia Pacific Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.4.2. Asia Pacific Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of APAC
5.5. Latin America Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.5.1. Latin America Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.5.2. Latin America Seborrheic Keratosis Treatment Market, by Country/Region, 2016 - 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Seborrheic Keratosis Treatment Market, 2016 - 2026 (US$ Mn)
5.6.1. Middle East & Africa Seborrheic Keratosis Treatment Market, by Treatment Type, 2016 - 2026 (US$ Mn)
5.6.2. Middle East & Africa Seborrheic Keratosis Treatment Market, by Region, 2016 - 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Aclaris Therapeutics, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Cortex Technology ApS
6.3. CryoConcepts LP
6.4. Cryoswiss GmbH
6.5. DRE Medical, Inc.
6.6. EpiPharm AG
6.7. H&O Equipments SA
6.8. Orasure Technologies, Inc.
6.9. Special Medical Technology Co., Ltd.
6.10. Wallach Surgical Devices, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/ndwq2x/seborrheic?w=12